Plaintiffs hiring an attorney and seeking compensation for Pradaxa injuries usually do so as a result of severe bleeding events. Pradaxa, meant to be an alternative to warfarin, has no readily available antidote for serious bleeding events, making these incidences particularly dangerous. Some patients have... Read More

A new lawsuit was filed against the anti-coagulant drug Pradaxa was filed on August 23, 2012 in the U.S. District Court for the Western District of Missouri (St. Joseph Division). Shirley Jean Higdon’s filing a Pradaxa lawsuit against Boehringer Ingelheim Pharmaceuticals is considered a tag-along... Read More

Pradaxa lawyers are involved in a lawsuit filed by a Tennessee man who claims that the blood thinning medication caused the death of his mother on the 7th of April, 2011. Plaintiff James Lunsford filed suit on August 8, 2012, in the United States' District... Read More

Pradaxa is a blood thinning medication that has been linked to a number of serious side effects and even deaths since it was introduced on the market. Brain hemorrhage, gastrointestinal bleeding, and internal bleeding have led to Pradaxa related deaths, which in turn have led... Read More

Boehringer Ingelheim Pharmaceuticals, the manufacturer of the anti-coagulant drug Pradaxa, requested that the judge dismiss a complaint seeking compensation due to side effects of Pradaxa. Chief Judge David R. Herndon, who presides over the U.S. District Court for the Southern District of Illinois, denied the... Read More

A patient who had to be hospitalized for nine days due to life-threatening Pradaxa gastrointestinal bleeding has filed a lawsuit against Boehringer Ingelheim, manufacturer of the blood-thinning medication. The plaintiff filed his lawsuit on August 14, 2012 in the United States District Court, Eastern District... Read More

The United States' Judicial Panel on Multidistrict Litigation signed an order that consolidated all federal bleeding-related Pradaxa suits into one court in Illinois on the 8th of August, 2012. Judge David R. Herndon has been assigned to oversee the pretrial proceedings that will take place... Read More

Pradaxa, an anticoagulant drug, was originally marketed as a superior drug to Coumadin. The drug is designed to reduce the risk of stroke and blood clotting in people who are experiencing non-valvular atrial fibrillation. Since first being approved by the U.S. Food and Drug Administration... Read More